Insulin-mediated sodium retention is implicated as a mechanism for hypertension in 38 metabolic syndrome and Type II diabetes. However, there is no direct experimental evidence for 39 a sustained antinatriuretic effect of insulin outside of rodents, and all previous studies in dogs 40 have been negative. This study used a novel approach to test for a chronic sodium retaining 41 action of insulin in dogs, by testing the hypothesis that natriuresis in Type I diabetes is dependent 42 on the decrease in insulin, rather than being due solely to osmotic actions of hyperglycemia. 43 Dogs were chronically instrumented and housed in metabolic cages. Fasting blood glucose in 44 alloxan-treated dogs was maintained at ~65 mg/dl by continuous iv. insulin infusion. Then a 6-45 day diabetic period was induced by either: 1) decreasing the insulin infusion to induce Type I 46 diabetes (D; blood glucose = 449±40 mg/dl), or 2) clamping the insulin infusion and infusing 47 glucose continuously (DG; blood glucose = 470±56 mg/dl). Control urinary sodium excretion 48 (UnaV) averaged 70±5 (D) and 69±5 (DG) mEq/day, and increased on day 1 in both groups. 49
INTRODUCTION 57 58
Early observations in diabetic human subjects showed acute natriuresis following abrupt 59 withdrawal of insulin therapy and antinatriuresis upon resumption of insulin therapy, suggesting 60 that insulin could affect renal sodium excretion (2). Subsequently, DeFronzo et al (17) showed 61 that acute insulin infusion in euglycemic human subjects significantly decreased urinary sodium 62 excretion due most likely to stimulation of tubular reabsorption. Numerous studies have 63 supported that finding by showing significant decreases in urinary sodium excretion during acute 64 insulin infusion in animals (18, 22, 30, 36) and humans (20, 46, 48) , and insulin-mediated 65 sodium retention has been hypothesized to cause hypertension, particularly in obese subjects (16, 66 19, 31, 39-41, 44, 50) . 67
However, the only chronic data that support a sodium-retaining or hypertensive action 68 come from rodent studies (10, 11, 35, 47, 51) . In fact, chronic insulin infusion studies in dogs 69
have not found any evidence for a direct sodium retaining effect (12, (24) (25) (26) . Therefore, it has 70 been exceedingly difficult to translate the results from acute insulin infusion studies and chronic 71 rat studies that support a sodium-retaining hypothesis to any chronic sodium-retaining action in 72
humans. 73
To address this problem and test whether insulin has a direct renal sodium retaining 74 action in dogs, we developed a unique experimental approach. Typical insulin infusion studies 75 achieve hyperinsulinemia while simultaneously maintaining normal plasma glucose levels, i.e. a 76 euglycemic clamp. Although that is a sound experimental design to isolate insulin as an 77 independent variable, it creates a condition that does not mimic the insulin-glucose relationship 78 found either in Type I diabetes (which is low insulin and very high glucose) or in metabolic6 148
Analytical Procedures 149
Fasting blood samples (21 hrs postprandial) were drawn during the control period, on 150 diabetes days 2 and 5, and during the recovery period in all dogs in both groups. On the same 151 days, glomerular filtration rate (GFR) was determined from the total plasma clearance of I 125 -152 labeled iothalamate (Glofil; QOL Medical, Kirkland, WA) over a 3-hour period from 0800-1100 153 while the dogs rested quietly in their cages (9, 27) . Urine sodium, potassium, and lithium 154 concentrations were determined by atomic absorption, plasma electrolytes were measured by 155 ion-sensitive electrodes (MEDICA Easy Electrolytes, Bedford, MA), plasma protein 156 concentration was measured by refractometry, blood glucose was measured with an Accu-Check 157 meter (Roche, Indianapolis, IN), urine glucose was measured using a glucose assay kit (Sigma-158
Aldrich, St. Louis, MO), osmolality was measured by freezing point depression (Advanced 159
Instruments, Norwood, MA), plasma insulin was measured using an EIA kit from ALPCO 160 Diagnostics (Salem, NH), and plasma renin activity (PRA) was measured by radioimmunoassay 161 (Diasorin, Stillwater, MN). Daily electrolyte and water balances were calculated as: intake -162 output -insensitive loss, where insensitive loss equaled average intake during the control period -163 average output during the control period. Therefore, cumulative balance equals zero on the last 164 day of the control period. 165
Data from D and DG dogs were analyzed with 2-factor repeated measures analysis of 166 variance (ANOVA) using GraphPad Prism software. At p < 0.05 for the within-subjects F-test in 167 the ANOVA, Dunnett's test was used to determine which experimental-period day differed from 168 control. The control for time in this experimental design is the recovery period, and for variables 169 with multiple recovery period days, an average recovery period value was determined and usedin the ANOVA. At p < 0.05 for the between-subjects F-test in the ANOVA, bonferroni test was 171 used to determine on which days the two groups differed. 
RESULTS

177
Glucose and Insulin 178
All dogs in this study were treated with alloxan, and all dogs were placed on daily 179 insulin replacement (Insulin Rx) to maintain normal blood glucose. Glucose was measured once 180
per day under fasting conditions in all dogs at 0800 hours to minimize variability. These dogs 181
were assigned randomly to either the D or DG groups, and Figure 1 shows that the 24 hr/day 182 Insulin Rx dose was stable and not different between groups during the baseline period. Figure 2  183 shows that fasting blood glucose also was not different between groups at baseline. Thus, there 184 was no difference in the, surgery, housing, preparation, daily care, or treatment of dogs in the D 185 vs. DG group prior to the 6-day diabetic period, and this is supported by the baseline insulin and 186 glucose data. 187
Diabetes was induced in the D group by decreasing the insulin replacement dose (Figure  188 1, gray bars). The decrease in plasma insulin is shown in Table 1 , and the increase in blood 189 glucose that resulted is shown in Figure 2 (gray bars). Therefore, the D group had typical Type I 190 diabetes, with low insulin and high blood glucose. In the DG group, the control-period insulin 191 replacement dose was clamped at that rate and maintained (Figure 1 , black bars) while 192 hyperglycemia was induced by infusing glucose iv. 24 hr/day. The glucose infusion wasadjusted as needed in each dog to raise blood glucose to the same level as in the D group (Figure  194 
2, black bars). 195
Fasting blood glucose averaged 64 ± 4 and 68 ± 8 mg/dl in the D and DG groups, 196 respectively, during the last 3 days of control (Figure 2) , and increased significantly in both 197 groups and not differently between groups over the 6-day diabetic period, averaging 449 ± 40 198 and 470 ± 56 mg/dl in the D and DG groups, respectively. It was important that the glucose 199 infusion rate in the DG dogs did not have to be increased during the diabetic period to maintain 200 the elevated blood glucose levels, because that would have indicated there was glucose-induced 201 insulin release occurring in the background; therefore, this was additional verification that 202 endogenous insulin secretion did not increase in response to the glucose infusion. Table 1 shows 203 that plasma osmolarity increased to similar levels in both groups during the diabetic period, 204 which reinforces the similar levels of hyperglycemia measured. 205
206
Sodium Excretion and Fluid Balance 207
Urinary sodium excretion was not different between groups during the control period 208 (Figure 3) , and total water intake averaged 2194 ± 163 and 2170 ± 77 ml/day in the D and DG 209 groups, respectively. On the first day of diabetes urinary sodium excretion increased 210 significantly in both groups (Figure 3) , and that is consistent with the early measurements of 211 increased urinary osmolar clearance (Table 2 ) and decreased extracellular fluid volume (ECFV, 212 Table 1 ) in both groups. However, there was a dramatic divergence in the sodium and volume 213 excretory responses from the second diabetic day onward, with urinary sodium excretion 214 increasing further and being sustained in the D dogs, but with the natriuresis being virtuallyintake being clamped at the same level in both groups. This is consistent with the D group 217 having significantly greater urine osmole excretion (Table 2 ) and significantly lower plasma 218 sodium concentration (Table 1) than the DG group, and also having a significant increase in 219 renal sodium clearance ( Table 2 ). The differences in cumulative sodium balance (Figure 4 ) 220 show the integrated consequences of these effects over the 6-day period. 221
The sodium excretion data are consistent with the continued decrease in ECFV in the D 222 group but not the DG group (Table 1 Table 2 shows that lithium clearance in the DG group decreased significantly during 233 diabetes and returned to normal during the recovery period. Figure 5 shows that fractional 234 lithium reabsorption increased significantly during diabetes in the DG group, but decreased 235 transiently in the D group. These data are consistent with increased proximal tubular sodium 236 reabsorption in the DG dogs during the diabetic period. Our initial measurements of urinary 237 glucose excretion showed that it was significantly lower in the DG versus D dogs during 238 diabetes, averaging 335 ± 114 and 251 ± 118 mg/day on days 2 and 5 of diabetes, respectively,for DG, and 551 ± 161 and 604 ± 166 mg/day on days 2 and 5, respectively, for D. However, 240 that range from approximately 250 to 600 mg/day is considerably lower than the approximately 241 65 to 260 grams/day previously reported using acute urine collection in diabetic dogs (14, 45) . 242
We measured urine glucose concentration at the conclusion of the study from samples stored 243 under refrigeration, and after obtaining these low values we analyzed small frozen aliquots of 244 urine we had saved from 4 dogs in each group. That analysis showed 24-hour urinary glucose 245 excretion to be in the 20 gram/day range. The finding of lower excretion in DG vs. D dogs was 246 preserved, and those are the data shown in Table 2 . Plasma renin activity (PRA) increased on 247 diabetes day 2 in the DG dogs (Table 1) , suggesting a potential role for the renin angiotensin 248 system in the early-stage sodium retention. The renal blood flow (RBF, Figure 6 ) and GFR 249 (Table 2 ) responses showed no evidence of vasoconstriction, which also supports a tubular 250 mechanism for the sodium retention. Mean arterial pressure averaged 104 ± 4 and 105 ± 2 251 mmHg in the D and DG dogs, respectively, and did not change during diabetes in either group, 252 and because there also were no differences in GFR (Table 2) Increased urinary sodium excretion is a hallmark of Type I diabetes, and we hypothesized 258 that preventing the decrease in insulin would attenuate the increase in urinary sodium excretion, 259 thereby providing the first direct experimental evidence for a chronic sodium retaining action of 260 insulin in a non-rodent model. Surprisingly, however, we found that maintaining plasma insulin 261 at baseline levels completely abolished the natriuresis after one day and returned sodiumexcretion to normal despite persistent hyperglycemia. This was shocking in light of the classic 263 textbook dogma that an osmotic diuretic effect of glucose in diabetes is responsible for the 264 tremendous urinary salt and volume losses (5, 23, 52), so much so that persistent hyperglycemia 265 is believed to cause "massive salt and water depletion, and cardiovascular collapse may ensue." 266 (52) Yet we did not measure any progressive salt depletion, decreased extracellular fluid 267 volume, or decrease in blood pressure in the DG group. Therefore, not only do these data 268 provide direct evidence for a sustained sodium retaining effect of insulin that is linked to 269 hyperglycemia, but they also challenge a long-held concept regarding the mechanism for renal 270 salt and water loss in diabetes. 271
The marked natriuresis on day 1 of diabetes of course is consistent with that concept, and 272 strongly suggests that hyperglycemia was the mediator of the initial, transient, rise in sodium 273 excretion. Because RBF was not increased on day 1 of diabetes, the natriuresis that day likely 274
was not a consequence of renal vasodilation. This is consistent with two recent findings from 275 our laboratory: First is that chronic blockade of nitric oxide synthesis prevented the increases in 276 GFR and RBF caused by onset of Type I diabetes in rats (consistent with other reports (32, 49)), 277 but did not attenuate the natriuretic response (6). Second is that induction of Type I diabetes in 278 rats with reduced kidney mass, in which GFR was decreased 50% at baseline and did not 279 increase during diabetes, caused significant natriuresis that was not different from rats with 280 normal kidney mass and increased GFR (42). These data support the natriuretic effect of 281 hyperglycemia in diabetes. 282
However, the sodium excretory responses measured on diabetes days 2-6 show that the 283 sustained natriuresis during Type I diabetes was dependent entirely on the decrease in insulin, 284 because maintenance of baseline insulin levels was able to counteract the natriuretic effect ofsustained hyperglycemia. Numerous studies have shown that insulin infusion or administration 286 can decrease sodium excretion or increase tubular sodium transport (10, 11, 18, 20, 22, 30, 35, 287 46-48, 51) . However, all studies that have shown direct antinatiuretic actions of insulin have 288 been acute studies in humans or other species or chronic studies in rodents, and the sodium 289 retention reported previously during chronic iv. insulin infusion dogs was indirect, due to the 290 drop in blood pressure and withdrawal of pressure natriuresis (12, 25, 26) . That was reinforced 291 by the lack of sodium retention during chronic intra-renal insulin infusion in dogs (24). A 292 critical difference in our approach in this study is that we did not infuse insulin to induce 293 hyperinsulinemia, but instead tested the role of the insulin depletion that occurs Type I diabetes. 294
As presented in the Methods, our only blood samples for measuring insulin, as well as glucose, 295
were 21 hours postprandial, and whether those variables changed differently between groups in 296 response to the daily meal is not known. Therefore, our strongest evidence that our experiment 297 tested the role of insulin depletion is the significant difference in 24-hour insulin replacement 298 doses shown in Figure 1 . Maintenance of the control-period insulin replacement dose during 299 hyperglycemia in the DG group showed that the loss of insulin is what enables persistent 300 hyperglycemia to cause sustained natriuresis, thereby revealing a sustained sodium retaining 301 action of insulin. 302
Most evidence for insulin-induced antinatriuresis implicates action in the distal nephron 303 (17, 18, 20, 47, 48) , possibly through modulation of ENaC or sodium-chloride cotransport (47) . 304
There also is evidence that insulin can stimulate chloride transport in the loop of Henle (30) and 305 increase sodium-potassium ATPase (18) and sodium-hydrogen exchanger activity (21, 22) However, the measurement of decreased fractional lithium reabsorption in the D group was 309 surprising in light of evidence that proximal fractional sodium reabsorption is increased in 310 diabetes (34, (54) (55) (56) . In fact, we previously have invoked this as a mechanism that contributes 311 significantly to renal vasodilation in diabetes, by causing the macula densa to sense a decrease in 312 sodium chloride delivery (6, 7). This mechanism for withdrawal of tubulogomerular feedback 313 (TGF) has been proposed by other laboratories as well to explain renal vasodilation (54-56), and 314
we used transfer function analysis to show blunting of TGF feedback gain in conscious diabetic 315 rats (6, 7). Because the current results were at odds with these other findings, we also estimated 316 proximal fractional sodium reabsorption in both groups from our electrolyte and osmolar 317 excretion data according to the following formula: (100-{[U Na+K x V)/(GFR x P Na )] x 100%} -318
[(C H2O /GFR) x 100%]) (55), and we obtained the same changes as shown by lithium clearance. 319
We cannot explain why we saw no evidence for increased fractional proximal sodium 320 reabsorption in the D group. These measurements during the first 5 days of diabetes are not 321 possible in humans and to our knowledge have not been reported in chronically instrumented 322 dogs, so whether different results would have been measured in longstanding diabetes or at a 323 different level of hyperglycemia is not known. Likewise, we cannot rule out a role for more 324 distal nephron sites in mediating the sodium reabsorption. In addition, a limitation inherent in 325 chronic animal studies is that 24 hour electrolyte excretion must be coupled with single-point 326 GFR values to calculate electrolyte clearance and fractional excretion. Nevertheless, these data 327 support a role for proximal tubular reabsorption contributing to sodium reabsorption during 328 diabetes in the DG group. 329
It is interesting, to consider a potential effect in the proximal tubule in this experimental 330 model, because insulin was studied in the context of hyperglycemia rather than under euglycemicclamp. Glucose already is known to increase absolute proximal tubular sodium reabsorption in 332 diabetes through sodium-glucose cotransport (SGLT) (3, 37, 54, 57) , and our data showing 333 decreased urinary glucose excretion in the DG versus the D dogs, together with increased lithium 334 reabsorption in the DG dogs, is consistent with increased SGLT action. In addition, serum-and 335 glucocorticoid-inducible kinase (SGK1), typically linked to the distal nephron (8), recently has 336 been shown to regulate proximal tubular glucose transport (1), be stimulated by glucose (1, 43) 337 and insulin (28, 33), and to regulate NHE3 activity in the proximal tubule (21). Therefore, an 338 intriguing question is whether an effect of glucose to stimulate proximal tubular sodium 339 reabsorption was potentiated by maintenance of baseline insulin, possibly via SGK1-driven 340 SGLT and/or NHE3 activity. Although that mechanism is speculative at this point, our data 341 nonetheless suggest that insulin and glucose may have acted together to stimulate proximal 342 sodium reabsorption. 343
Evidence supporting a cooperative effect of insulin and glucose to stimulate sodium 344 reabsorption is that fractional lithium reabsorption increased significantly in the DG group. If 345 the maintenance of normal insulin in the DG group simply had "blocked" the natriuretic effect of 346 hyperglycemia, then fractional lithium reabsorption should have remained flat at baseline levels 347 and tracked parallel to total urinary sodium excretion In other words, urinary sodium excretion 348 in the DG group returned to control levels, but it was accompanied by increased factional lithium 349 reabsorption. This not only is indicative of increased proximal tubular sodium reabsorption, but 350 it also means that hyperglycemia continued to exert a natriuretic effect during the diabetic 351 period, or else the increased sodium reabsorption caused by insulin would have increased 352 cumulative sodium balance, rather than simply preventing the decrease. In addition, the 353 stimulation of proximal reabsorption that occurred when the kidneys of the DG dogs werepresented with increased glucose suggests that hyperglycemia may have acted in concert with 355 insulin, or "triggered", an effect of insulin to stimulate sodium reabsorption. Thus, the chronic 356 sodium-retaining action of insulin was powerful enough to counteract the glucose-induced 357 natriuresis, but it appears actually to require diabetic levels of hyperglycemia to become active. 358
The sodium retaining action did not increase blood pressure, and that may be because the 359 net effect of that action was to prevent a hyperglycemia-induced decrease in cumulative sodium 360 balance. GFR also did not change significantly in either group, which is peculiar given the 361 general association of increased GFR with Type I diabetes. A potential explanation is that GFR 362 was measured over a 3-hour period that started 21 hrs from the last meal, and thus does not 363 incorporate postprandial changes that may have occurred. Blood samples from all dogs are taken 364 always while they are resting quietly in the post-absorptive or fasting state to minimize 365 variability, so this is an inherent limitation that results in a short window for GFR measurement 366 and only on selected days during the study. Therefore, we developed the ability to measure RBF 367 continuously throughout the day as one approach to measure renal hemodynamics over a longer 368 period, not only throughout each day, but every day during the study (9). In fact we used a 369 similar RBF method in rats to show that GFR and RBF increase in parallel in Type I diabetes (7). 370
Renal blood flow in these dogs did increase modestly; however, the change was transient. This 371 suggests that our GFR results may not have been due solely to the conditions under which it was 372 measured. GFR and RBF have been reported to be elevated in alloxan-induced diabetes in dogs 373 1 or more years after induction (13, 29), but we are not aware of any previous studies reporting 374 GFR and RBF in Type I diabetic dogs during the first week of induction, and there are very little 375 renal function data in conscious subjects during the first week of diabetes in any species (7, 53) . 376
Although an explanation for the renal hemodynamic response is not apparent, 377
hemodynamics are important to consider because changes in sodium excretion or clearance can 378 reflect differences in filtered sodium due to renal vasoconstriction and/or sodium reabsorption, 379 which also can have a vasoconstrictor component. Our continuous RBF measurements were 380 critical, therefore, in providing evidence that renal vasoconstriction did not cause the sustained 381 return of sodium excretion to normal in the DG group. For example, because GFR was 382 measured only over a 3-hr period twice during the diabetic period, we cannot rule out that the 383 decrease in urinary sodium excretion on diabetes D2 in the DG group was not due in part to a 384 combination of afferent arteriolar dilation and efferent arteriolar constriction (PRA was elevated 385 on D2), that increased GFR, maintained RBF, and therefore increased filtration fraction. 386
However, the 18-hour daily RBF data, that show sustained normal sodium excretion with an 387 increase in RBF on subsequent days, argue strongly against renal vasoconstriction mediating that 388 sodium retaining action. Therefore, although not ruling out any role for vasoconstriction, the 389 fact that there were no differences in MAP, GFR, or RBF between the two groups suggests it is 390 unlikely that hemodynamic mechanisms explain the markedly different sodium excretory 391 responses between the two groups over the 6-day diabetic period. 392
Thus, the fundamental observation in this study is that sustained hyperglycemia, over 393 400 mg/dl for 6 days in dogs, did not cause sustained natriuresis when circulating insulin was 394 maintained at baseline levels. Our results do not exclude potential systemic actions of insulin, 395 because insulin is known to stimulate the sympathetic nervous system (4, 15, 38), and there 396 likely were differences in insulin-dependent glucose uptake in insulin-sensitive tissues between 397 the D and DG groups as well. Nonetheless, our data are consistent with sustained stimulation of 398 renal tubular sodium reabsorption by insulin, possibly in the proximal tubule. In addition, thateffect appears to be due to interaction between insulin and tubular glucose and to be powerful 400 enough to oppose a sustained natriuretic influence of hyperglycemia. The renin angiotensin 401 system may have been involved during the first few days, and the possibility that insulin and 402 glucose affected sodium transport by SGLT, perhaps via SGK1, is interesting to consider. It also 403 is intriguing to extrapolate from these findings and consider whether protecting against glucose-404 induced renal sodium loss is a normal, physiologic function of insulin that simply has not been 405 recognized previously. Such an action might be operative postprandially, for example, but it also 406 may mean that maintenance of sodium balance during the progression of metabolic syndrome 407 and uncontrolled Type II diabetes, in which plasma insulin and glucose both are elevated 408 chronically, is due to a cooperative effect of insulin and glucose in the renal tubule to counteract 409 and prevent progressive sodium loss from the sustained hyperglycemia. That hypothesis, 410 however, will require further study. 
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